Delivery of rapamycin to dendritic cells using degradable microparticles.
about
Ex vivo cytosolic delivery of functional macromolecules to immune cellsPeriadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosisMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionBiomedical Applications of Biodegradable Polymers.Immunoregulatory functions of mTOR inhibition.Designing the optimal vaccine: the importance of cytokines and dendritic cells.Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.Formulation Development and Toxicity Assessment of Triacetin Mediated Nanoemulsions as Novel Delivery Systems for RapamycinEffect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscleBioinspired controlled release of CCL22 recruits regulatory T cells in vivoSolid Lipid Nanoparticles (SLNs) for Intracellular Targeting ApplicationsPreformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.Materials that harness and modulate the immune system.Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacitiesElectrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.Development of dendritic cell-based immunotherapy for autoimmunity.Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheresMultifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.Microparticulate systems for targeted drug delivery to phagocytes.Keratin hydrogels support the sustained release of bioactive ciprofloxacin.An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.Designing improved poly lactic-co-glycolic acid microspheres for a malarial vaccine: incorporation of alginate and polyinosinic-polycytidilic acid.Facile assembly and loading of theranostic polymersomes via multi-impingement flash nanoprecipitation.Modulating the immune system through nanotechnology.Multiple noncovalent interactions mediated one-pot therapeutic assemblies for the effective treatment of atherosclerosisSynthesis of nano- and microstructures from proanthocyanidins, tannic acid and epigallocatechin-3-O-gallate for active delivery
P2860
Q21131808-16556D89-B7AF-4DC7-A5CE-839B2740C0A3Q27321271-BBB3E2FB-8994-4CC9-8301-FFC356BA6AB5Q28080720-F6845B1E-9F53-45C8-8650-5B3075FD75CFQ30426452-B3FA950B-3215-4E11-80D4-8F5E1B1B1DD1Q33761278-2BAACDC7-A559-431D-82FF-0A2CAAAA8A02Q35146556-4BB49515-9464-4A56-A62E-4062A213E861Q35286959-82AFE9DD-9BCD-4A4E-9484-72A2A3B29473Q35843283-5F3B2F47-93B7-44C7-A8F8-FE9F8C0ED066Q35943638-BDFE6B2E-EA13-49B9-9407-F6A3B270A917Q36379675-CB3C2565-383A-4224-9248-6BADA66F03F6Q36408352-0700FFF6-3621-4B16-9FFF-4E43CFA4A6CAQ36549331-00C1A6E6-4B1F-4001-9369-19E4B8B99782Q36690859-1D0635D5-F6FC-4BEF-B721-4DE45FE26624Q36998551-4450B658-D653-4696-A967-A56390D36517Q37238282-4909B606-6D87-4D11-8DC6-9E0763D292F9Q37378031-EA6EC58C-B658-42D8-92F1-5652C194BA51Q37521185-FB09655D-C848-4DA4-B13A-AF85083C05D9Q37701864-47944FAB-E5C0-42D8-A18F-FA480DA433A7Q37723891-E161F678-AB2C-4B78-B27E-B94293381B37Q37820820-364E3655-2D45-4BA3-A30B-A0DC2AFABAAEQ42862823-C602C442-1C42-44A1-9A10-42BB016E1407Q44966901-E4A28240-C511-471F-829A-3F2D52E0568EQ47848180-D2DFB970-21D5-4258-A478-E990C3DA4197Q47862273-EC845120-997D-416B-82C7-4C9F460516B6Q47890422-353926F1-01CA-47E7-9D49-1264608037CCQ48630939-1147F101-3DE3-4550-A84E-DEE4D32CA0F4Q57366868-FC3869EF-20E5-4336-8BC5-BD54480EF853Q58484613-FFE7825B-98C9-4889-A162-81B2679632FC
P2860
Delivery of rapamycin to dendritic cells using degradable microparticles.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Delivery of rapamycin to dendritic cells using degradable microparticles.
@en
type
label
Delivery of rapamycin to dendritic cells using degradable microparticles.
@en
prefLabel
Delivery of rapamycin to dendritic cells using degradable microparticles.
@en
P2860
P1476
Delivery of rapamycin to dendritic cells using degradable microparticles
@en
P2093
A W Thomson
G Raimondi
P2860
P304
P356
10.1016/J.JCONREL.2008.10.011
P407
P577
2008-10-26T00:00:00Z